ganglioside
Animal productexperimental
A ganglioside is a molecule composed of a glycosphingolipid with one or more sialic acids linked on the sugar chain. NeuNAc, an acetylated derivative of the carbohydrate sialic acid, makes the head groups of gangliosides anionic at pH 7, which distinguishes them from globosides. — Wikipedia
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2007 (NCT02139709)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaGanglioside ↗
Also known as
- ganglioside
- ganglioside
- gangliosides
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05239663 | Phase 3 | Feb 8, 2022 | Sun Yat-Sen University |
| NCT02234024 | N/A | Jan 1, 2014 | DDC Clinic |
| NCT02139709 | Phase 1 | Jan 1, 2007 | University of Alberta |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| DDC Clinic | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| University of Alberta | Academic/Hospital | 1 | 1 | 1 | 2007 |
3 organizations
Page 1 / 1